CdGAP Activators belong to a specialized class of chemical compounds that are designed to specifically interact with the cellular protein known as Cdc42 GTPase-activating protein, abbreviated as CdGAP. The role of CdGAP in cellular biology is to regulate the activity of the Rho family of GTPases, particularly Cdc42, which is instrumental in various cellular processes including the regulation of the actin cytoskeleton, cell morphology, and migration. Activators of CdGAP influence this regulation by promoting the GTPase-activating function of CdGAP, which, in turn, accelerates the conversion of the active GTP-bound form of Cdc42 to its inactive GDP-bound form. By doing so, these activators can modulate the dynamics of cell shape and motility. The precise molecular mechanisms by which CdGAP activators exert their influence involve binding to specific domains within the CdGAP protein, which can lead to conformational changes that enhance CdGAP's intrinsic GTPase-activating activity.
The development of CdGAP activators is a complex field that requires an in-depth understanding of protein chemistry and cell signaling pathways. These compounds may be small organic molecules, peptides, or other forms of biologically active substances that have been identified through various high-throughput screening techniques or rational drug design methods. The interaction between CdGAP activators and the CdGAP protein is highly specific, relying on the precise alignment of molecular structures and the establishment of various non-covalent interactions, such as hydrogen bonding, hydrophobic forces, and van der Waals interactions. This high degree of specificity is crucial for the effective modulation of CdGAP activity, as off-target effects could interfere with the complex network of signaling pathways within the cell.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lysophosphatidic Acid | 325465-93-8 | sc-201053 sc-201053A | 5 mg 25 mg | $98.00 $341.00 | 50 | |
Acts on G protein-coupled receptors to activate Rho GTPases signaling pathways, which can modulate CdGAP activity. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
ROCK inhibitor, can increase GTP-bound RhoA, thereby potentially increasing the activity of CdGAP to convert it to its inactive GDP-bound state. | ||||||
Simvastatin | 79902-63-9 | sc-200829 sc-200829A sc-200829B sc-200829C | 50 mg 250 mg 1 g 5 g | $31.00 $89.00 $135.00 $443.00 | 13 | |
Inhibits HMG-CoA reductase, leading to reduced prenylation of Rho GTPases, indirectly influencing CdGAP's regulatory actions. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Activates adenylate cyclase, increases cAMP, which can modulate RhoA activity, and consequently CdGAP activity. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Activates protein kinase C (PKC), which can influence Rho GTPase signaling and CdGAP activity. | ||||||
Guanosine 5′-O-(3-thiotriphosphate) tetralithium salt | 94825-44-2 | sc-202639 | 10 mg | $465.00 | ||
Non-hydrolyzable GTP analogue, can bind to Rho GTPases and may indirectly enhance CdGAP activity as part of feedback regulation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
Increases intracellular calcium, which can activate calcium-sensitive proteins that regulate Rho GTPases and CdGAP. | ||||||
Manganese | 7439-96-5 | sc-250292 | 100 g | $270.00 | ||
Can activate integrins, which can signal through Rho GTPases and potentially affect CdGAP activity. | ||||||
NSC 23766 | 733767-34-5 | sc-204823 sc-204823A | 10 mg 50 mg | $151.00 $609.00 | 75 | |
Inhibitor of Rac1, altering Rho GTPase crosstalk, which may impact CdGAP function. | ||||||